Forbes India: How drug companies can increase their R&D effectiveness

A study co-authored by Professor Stylianos Kavadias and Dr Nektarios Oraiopoulos at University of Cambridge Judge Business School, is featured in the Forbes article. The study demonstrates “how pharmaceutical executives can impact the success of their research and development” programs by carefully assessing and acting on information signals from their competitors.” (subs)

Read the full article [forbesindia.com]